IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9440980 B1

PDFFull Text
Date of Patent:
Sep. 13, 2016

Filed:

Apr. 25, 2014

Remedy for diabetes

Applicant:

Ea Pharma Co., Ltd., Tokyo, JP;

Inventors:

Naoyuki Fukuchi, Kawasaki, JP;

Satoru Okamoto, Kawasaki, JP;

Wataru Miyanaga, Kawasaki, JP;

Sen Takeshita, Kawasaki, JP;

Masaru Takayanagi, Kawasaki, JP;

Yumiko Fukuda, Kawasaki, JP;

Takao Ikenoue, Kawasaki, JP;

Naoyuki Yamada, Kawasaki, JP;

Naoko Arashida, Kawasaki, JP;

Assignee:

EA PHARMA CO., LTD., Tokyo, JP;

Attorney:

Oblon, McClelland, Maier & Neustadt, L.L.P

Primary Examiner:

Jeffrey H Murray

Int. Cl.
CPC ...
A01N 43/62 (2006.01); A61K 31/55 (2006.01); C07D 491/00 (2006.01); C07D 513/00 (2006.01); C07D 515/00 (2006.01); C07D 243/10 (2006.01); C07D 487/12 (2006.01); C07D 487/04 (2006.01); A61K 31/551 (2006.01); C07D 519/00 (2006.01); G01N 33/68 (2006.01); C12Q 1/48 (2006.01); G01N 33/50 (2006.01); G01N 33/573 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/55 (2013.01); A61K 31/551 (2013.01); C07D 519/00 (2013.01); C12Q 1/485 (2013.01); G01N 33/5035 (2013.01); G01N 33/573 (2013.01); G01N 33/6845 (2013.01); G01N 33/6872 (2013.01); G01N 2333/4719 (2013.01); G01N 2333/91215 (2013.01); G01N 2500/04 (2013.01); G01N 2800/042 (2013.01);
Abstract

A method of screening a compound having a hypoglycemic effect (hereinafter referred to as 'hypoglycemic compound'), a remedy for diabetes which contains a compound having a novel function mechanism, etc. More specifically speaking, a method of screening a hypoglycemic compound capable of binding to the β subunit of a trimeric GTP-binding protein, a remedy for diabetes comprising a hypoglycemic compound, which is characterized by being capable of binding to the β subunit of a trimeric GTP-binding protein, as the active ingredient, etc.

Find Patent Forward Citations

Loading…